Showing results (1-10 of 10,203) with videos related to
Sort By:
Pageof 1,021
Neuropharmacology|June 1, 1991
Norepinephrine does not contribute to methamphetamine-induced changes in hippocampal serotonergic systemM Johnson, G R Hanson, J W GibbNeuropharmacology|November 1, 1988
Effects of dopaminergic and serotonergic receptor blockade on neurochemical changes induced by acute administration of methamphetamine and 3,4-methylenedioxymethamphetamineM Johnson, G R Hanson, J W GibbBiochemical Pharmacology|December 1, 1987
Effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE) on central serotonergic and dopaminergic systems of the ratM Johnson, G R Hanson, J W GibbBiochemical Pharmacology|December 1, 1989
Characterization of acute N-ethyl-3,4-methylenedioxyamphetamine (MDE) action on the central serotonergic systemM Johnson, G R Hanson, J W GibbEuropean Journal of Pharmacology|June 20, 1989
Effect of MK-801 on the decrease in tryptophan hydroxylase induced by methamphetamine and its methylenedioxy analogM Johnson, G R Hanson, J W GibbEuropean Journal of Pharmacology|December 7, 1995
Body temperature effect on methylenedioxymethamphetamine-induced acute decrease in tryptophan hydroxylase activityS Che, M Johnson, G R Hanson, et al.European Journal of Pharmacology|February 14, 1991
Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in neurotensin and dynorphin A systemsM Johnson, L G Bush, J W Gibb, et al.European Journal of Pharmacology|February 10, 1987
A comparison of the neurotoxic potential of methylenedioxyamphetamine (MDA) and its N-methylated and N-ethylated derivativesD M Stone, M Johnson, G R Hanson, et al.The Journal of Pharmacology and Experimental Therapeutics|October 1, 1988
Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamineD M Stone, M Johnson, G R Hanson, et al.Pageof 1,021